Spectral Instruments Imaging manufactures instruments for preclinical optical (bioluminescent, fluorescent) and X-ray imaging.
Automated microscopy and Spatial Proteomics
Automated microscopy and image analysis
Discover
Back to filter
Show all topics (10)
Related topics
Webinar recording: Deep dive into Spatial Biology with MERSCOPE Ultra Platform
Aug 16, 2024
We invite you to learn more about MERSCOPE Ultra Platform. Webinar featuring Rob Mathis (Global Instrument Product...
Single-Cell Genomics applications ? Ideal work for the WOLF gentle cell sorter
Aug 2, 2024
The field of genomics and computational biology has progressed immensely over the last decade and new single-cell...
Study finds that automated liquid-handling operations are more robust, resilient, and efficient!
Jul 18, 2024
Liquid handling devices (LHD) improve lab efficiency and accuracy. They automate liquid transfers, increase experiment...
Scaling Whole-Genome Sequencing to >50,000 single cells using cellenONE
Jul 16, 2024
cellenONE technology enabled the creation of tens of thousands of high-quality single-cell genomes, paving the way for...
Theranostics: From Mice to Men and Back
Jun 25, 2024
Recorded webinar
Presenters: Prof. Dr. Ken Herrmann and Prof. Dr. Katharina Lückerath – Moderator: Hannah Notebaert
Orion 2024 AACR poster: 17-plex single-step stain and imaging of cell Lung Carcinoma
Jun 21, 2024
RareCyte Orion is a benchtop, high resolution, whole slide multimodal imaging instrument. A combination of quantitative...
Automated Purification of Viral DNA and RNA from Biological Samples usingZymo Research Quick-DNA/RNA
Jun 14, 2024
The Quick DNA/RNA Viral MagBead Kit from Zymo has been automated with the Cybio FeliX pipetting robot from Analytik...
DNA Amplicon Library Preparation for Illumina® Sequencing
Jun 12, 2024
The precision of temperature control, efficient heating and cooling rates, and excellent temperature homogeneity across...
X-RAD 320 for irradiation therapy during quantifying study for in vivo collagen reorganization
Jun 5, 2024
Quantifying in vivo collagen reorganization during immunotherapy in murine melanoma with second harmonic generation...
Exosome-Mediated Delivery of Small Molecules, RNA & DNA for Development of Novel Cancer Therapeutics
Jun 3, 2024
Disha Moholkar of University of Louisville's Gupta Lab
Tuesday, June 11, 2024, 6:30 PM...
Evaluation with BLI of synthetic immune checkpoint engagers in allogenic mice
Jan 17, 2024
One of the most demanding challenges remaining for the field of regenerative medicine is the protection of allogeneic stem cell-derived therapeutics from immune rejection. Hypoimmune induced pluripotent stem cell (iPSC)-derived pancreatic beta cells for the treatment of type 1 diabetes mellitus are currently being developed and initial proof of concept has been established. Also, after initial success of autologous chimeric antigen receptor (CAR) T cells for the treatment of hematologic CD19+ cancers, next-generation allogeneic immune therapeutics are currently being developed. For regenerative and im-
mune-oncology products, gene-engineered immune evasion could make cell therapeutics fully resistant to immune rejection, thus turning them into universal off-the-shelf products at lower cost for larger patient populations.
Related technologies: Fluorescence, luminescence, X-ray, radiographic imaging
Get more info
Brand profile